Literature DB >> 10493178

Autoreactive T cells in murine lupus: origins and roles in autoantibody production.

J Craft1, S Peng, T Fujii, M Okada, S Fatenejad.   

Abstract

The conventional paradigm to explain systemic lupus erythematosus (SLE) is that disease results from tissue deposition of pathogenic autoantibodies and immune complexes, secondary to activation of autoreactive B cells in the context of help from alphabeta T cells. Recent work in murine lupus has confirmed this notion and demonstrated that autoantigen-specific alphabeta T cells are absolutely required for full penetrance of disease, with such autoreactive alphabeta T cells, even in Fas-intact mice, likely arising from defects in peripheral tolerance. These studies have also revealed a network of regulation that also involves nonclassical pathogenic and downregulatory alphabeta and gammadelta T cells, suggesting that the lupus immune system involves more complex interactions than the conventional paradigm suggests.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493178     DOI: 10.1007/BF02786492

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  83 in total

1.  Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.

Authors:  A Kretz-Rommel; S R Duncan; R L Rubin
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

2.  Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse.

Authors:  T N Marion; D M Tillman; N T Jou
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

3.  The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance.

Authors:  L Van Parijs; A Ibraghimov; A K Abbas
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

4.  Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo.

Authors:  D A Ferrick; M D Schrenzel; T Mulvania; B Hsieh; W G Ferlin; H Lepper
Journal:  Nature       Date:  1995-01-19       Impact factor: 49.962

5.  CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.

Authors:  J C Rathmell; M P Cooke; W Y Ho; J Grein; S E Townsend; M M Davis; C C Goodnow
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

6.  Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.

Authors:  S Fatenejad; W Brooks; A Schwartz; J Craft
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

7.  Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.

Authors:  A D Steinberg; J B Roths; E D Murphy; R T Steinberg; E S Raveche
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

8.  Treatment of murine lupus with CTLA4Ig.

Authors:  B K Finck; P S Linsley; D Wofsy
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

9.  Junctional region sequences of T-cell receptor beta-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens.

Authors:  S Adams; P Leblanc; S K Datta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Both intrathymic and peripheral selection modulate the differential expression of V beta 5 among CD4+ and CD8+ T cells.

Authors:  P J Fink; K Swan; G Turk; M W Moore; F R Carbone
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  11 in total

1.  T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells.

Authors:  Jiankun Zhu; Xuebin Liu; Chun Xie; Mei Yan; Ying Yu; Eric S Sobel; Edward K Wakeland; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

Review 2.  Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.

Authors:  Christopher M Reilly; Gary S Gilkeson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Immunological alterations in lupus-prone autoimmune (NZB/NZW) F1 mice by mycelia Chinese medicinal fungus Cordyceps sinensis-induced redistributions of peripheral mononuclear T lymphocytes.

Authors:  Jiun-Liang Chen; Yen-Chen Chen; Sien-Hung Yang; Yun-Fei Ko; Shao-Yuan Chen
Journal:  Clin Exp Med       Date:  2009-04-07       Impact factor: 3.984

4.  Defective B-cell response to T-dependent immunization in lupus-prone mice.

Authors:  Haitao Niu; Eric S Sobel; Laurence Morel
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

5.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.

Authors:  Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Felicia M Ellison; Jichun Chen; Neal S Young
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.

Authors:  Z Chen; S B Koralov; G Kelsoe
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

8.  Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity.

Authors:  A R Hamad; A Srikrishnan; P Mirmonsef; C P Broeren; C H June; D Pardoll; J P Schneck
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

9.  The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.

Authors:  Nicolas Page; Nicolas Schall; Jean-Marc Strub; Marc Quinternet; Olivier Chaloin; Marion Décossas; Manh Thong Cung; Alain Van Dorsselaer; Jean-Paul Briand; Sylviane Muller
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

10.  VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

Authors:  Mohamed A ElTanbouly; Yanding Zhao; Elizabeth Nowak; Jiannan Li; Evelien Schaafsma; Isabelle Le Mercier; Sabrina Ceeraz; J Louise Lines; Changwei Peng; Catherine Carriere; Xin Huang; Maria Day; Brent Koehn; Sam W Lee; Milagros Silva Morales; Kristin A Hogquist; Stephen C Jameson; Daniel Mueller; Jay Rothstein; Bruce R Blazar; Chao Cheng; Randolph J Noelle
Journal:  Science       Date:  2020-01-17       Impact factor: 63.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.